Success Factor 2: Increased cost-effectiveness of treatment and support
We need to understand which treatments and supports provide optimal value for money and the greatest returns on investment, and the most positive outcomes for individuals and the community.
- Improving cost-effectiveness of treatment and supports for people with an intellectual disability and co-occurring psychotic illness, Dr R Cvejic, Prof J Trollor, Dr S Reppermund, Dr P Srasuebkul, A/Prof J Lappin, Prof J Curtis, Prof K Dean, Prof K Samaras, Prof P Ward, Dr M O’Donnell, Dr A Walker University of New South Wales –$100,000.
- Evaluating the cost-effectiveness of programs, interventions, and services for people with psychosis, Dr. Kate Filia, Dr. Shuai Gao, and Cotton. Orygen –$100,000.
For further information about these research projects, contact Professor Alison Yung, Research Advisor Council Chair.
alison.yung@deakin.edu.au
